Duato Joaquin
SEC CIK 1673401 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | CEO, Dir | 399.3K | — | $89.39M | 35 | 2022-01-14 | 2026-08-13 |
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 16:35 | 2026-08-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $115.67 | +123.3K | 399.3K | +45% | +$14.26M |
| DM | 2026-08-14 16:35 | 2026-08-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | S - Sale+OE | $261.17 | -123.3K | 276.0K | -31% | -$32.20M |
| M | 2026-08-07 17:50 | 2026-08-05 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | S - Sale | $258.15 | -48.5K | 276.0K | -15% | -$12.52M |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +84.7K | 326.4K | +35% | $0 |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $244.44 | -36.2K | 324.4K | -10% | -$8.86M |
| MI | 2026-01-28 18:07 | 2026-01-26 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | S - Sale | $221.23 | -100.0K | 30.9K | -76% | -$22.12M |
| D | 2025-08-25 19:12 | 2025-08-22 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $101.87 | +125.8K | 401.8K | +46% | +$12.82M |
| D | 2025-08-25 19:12 | 2025-08-22 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | S - Sale+OE | $179.21 | -125.8K | 276.0K | -31% | -$22.55M |
| 2025-03-19 20:07 | 2025-03-18 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | G - Gift | $0.00 | -130.9K | 276.0K | -32% | $0 | |
| I | 2025-03-19 20:07 | 2025-03-18 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | G - Gift | $0.00 | +130.9K | 130.9K | New | $0 |
| DM | 2025-02-18 21:02 | 2025-02-13+ | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +31.5K | 415.2K | +8% | $0 |
| DM | 2025-02-18 21:02 | 2025-02-14+ | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $156.48 | -13.7K | 406.8K | -3% | -$2.14M |
| D | 2025-02-11 19:43 | 2025-02-07 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $100.06 | +126.4K | 489.7K | +35% | +$12.64M |
| D | 2025-02-11 19:43 | 2025-02-07 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $153.12 | -100.6K | 389.0K | -21% | -$15.41M |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +3,470 | 364.8K | +1.0% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $157.85 | -1,507 | 363.3K | -0.4% | -$237.9K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +36.6K | 377.2K | +11% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $157.40 | -15.9K | 361.3K | -4% | -$2.50M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $90.44 | +131.0K | 439.3K | +42% | +$11.84M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $156.76 | -98.7K | 340.6K | -22% | -$15.47M |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +5,225 | 310.6K | +2% | $0 |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $156.33 | -2,269 | 308.3K | -0.7% | -$354.7K |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | D - Sale to Iss | $0.00 | -11.0K | 305.4K | -3% | $0 | |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | A - Grant | $0.00 | +31.3K | 330.0K | +10% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $162.01 | -13.6K | 316.4K | -4% | -$2.20M |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +5,220 | 300.9K | +2% | $0 |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $162.08 | -2,267 | 298.7K | -0.8% | -$367.4K |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | M - OptEx | $72.54 | +148.5K | 394.5K | +60% | +$10.77M |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, COB, Dir | F - Tax | $173.43 | -98.8K | 295.7K | -25% | -$17.13M |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | M - OptEx | $0.00 | +29.7K | 258.9K | +13% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | F - Tax | $165.89 | -12.9K | 246.0K | -5% | -$2.14M |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | M - OptEx | $0.00 | +5,424 | 231.5K | +2% | $0 |
| D | 2022-02-15 20:04 | 2022-02-14 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | F - Tax | $168.85 | -2,356 | 229.2K | -1% | -$397.8K |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | M - OptEx | $65.37 | +84.4K | 280.5K | +43% | +$5.52M |
| D | 2022-01-19 20:54 | 2022-01-14 | JNJ | Johnson & Johnson | Duato Joaquin | CEO, Dir | F - Tax | $167.84 | -54.4K | 226.1K | -19% | -$9.13M |
Purchase Sale Sale after option exercise All abbreviations